Cellular mechanisms underlying the impairment of macrophage efferocytosis

• Published in: Immunology letters Vol. 254; pp. 41 - 53
• Main Authors: Ma, Yonggang, Kemp, Scott S., Yang, Xiaoyuan, Wu, Mack H., Yuan, Sarah Y.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.02.2023
• Subjects: Animals; Apoptosis; Efferocytosis; Inflammation; Inflammation resolution; Macrophage; Macrophages; Neutrophil; Phagocytosis; Signal Transduction; Efferocytosis; Neutrophil; Inflammation resolution; Phagocytosis; Apoptosis; Macrophage
• ISSN: 0165-2478; 1879-0542
• DOI: 10.1016/j.imlet.2023.02.001

•Efferocytosis is essential for maintaining homeostasis and promoting tissue repair.•Efferocytosis defects occur in a wide range of inflammatory and autoimmune diseases.•Enhancing efferocytosis promotes inflammation resolution and tissue repair. The phagocytosis and clearance of dying cells by macrophages, a process termed efferocytosis, is essential for both maintaining homeostasis and promoting tissue repair after infection or sterile injury. If not removed in a timely manner, uncleared cells can undergo secondary necrosis, and necrotic cells lose membrane integrity, release toxic intracellular components, and potentially induce inflammation or autoimmune diseases. Efferocytosis also initiates the repair process by producing a wide range of pro-reparative factors. Accumulating evidence has revealed that macrophage efferocytosis defects are involved in the development and progression of a variety of inflammatory and autoimmune diseases. The underlying mechanisms of efferocytosis impairment are complex, disease-dependent, and incompletely understood. In this review, we will first summarize the current knowledge about the normal signaling and metabolic processes of macrophage efferocytosis and its importance in maintaining tissue homeostasis and repair. We then will focus on analyzing the molecular and cellular mechanisms underlying efferocytotic abnormality (impairment) in disease or injury conditions. Next, we will discuss the potential molecular targets for enhanced efferocytosis in animal models of disease. To provide a balanced view, we will also discuss some deleterious effects of efferocytosis.